APH-1: Difference between revisions
CSV import |
CSV import |
||
| Line 32: | Line 32: | ||
[[Category:Cell signaling]] | [[Category:Cell signaling]] | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 02:59, 17 March 2025
APH-1
Overview[edit]
APH-1 is a component of the gamma-secretase complex, which is an intramembrane protease complex involved in the cleavage of several type I transmembrane proteins. The gamma-secretase complex plays a crucial role in the Notch signaling pathway and the processing of amyloid precursor protein (APP), which is implicated in Alzheimer's disease.
Structure[edit]
The APH-1 protein is a multi-pass transmembrane protein that is part of the gamma-secretase complex. It is believed to stabilize the complex and facilitate its assembly. APH-1 contains several transmembrane domains and is encoded by the APH1A and APH1B genes in humans.
Function[edit]
APH-1 is essential for the proper assembly and function of the gamma-secretase complex. It interacts with other components of the complex, including presenilin, nicastrin, and PEN-2. The gamma-secretase complex is responsible for the proteolytic cleavage of several substrates, including Notch receptors and APP.
Role in Notch Signaling[edit]
In the Notch signaling pathway, gamma-secretase cleaves the Notch receptor, releasing the Notch intracellular domain (NICD), which translocates to the nucleus to regulate gene expression. APH-1 is crucial for the stability and activity of the gamma-secretase complex in this pathway.
Role in Alzheimer's Disease[edit]
Gamma-secretase is involved in the cleavage of APP, leading to the production of amyloid-beta peptides. Accumulation of amyloid-beta is a hallmark of Alzheimer's disease. APH-1, as part of the gamma-secretase complex, is indirectly involved in this process, making it a target of interest in Alzheimer's research.
Genetic Variants[edit]
There are two main human genes encoding APH-1 proteins: APH1A and APH1B. These genes give rise to different isoforms of the APH-1 protein, which may have distinct roles in the gamma-secretase complex.
Research and Implications[edit]
Research into APH-1 and its role in the gamma-secretase complex is ongoing, with implications for understanding and potentially treating conditions such as Alzheimer's disease and cancers involving aberrant Notch signaling.
See Also[edit]
